Searched for
COVAXIN STORY
India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...- Adani Green Talks 2025 brings together changemakers; Gautam Adani calls for a "second freedom struggle"Adani Group's Green Talks convened innovators, entrepreneurs and changemakers to foster a sustainable future. Gautam Adani highlighted the ...
- Piyush Goyal demands apology from CM Siddaramaiah over vaccine remarksUnion Minister Piyush Goyal criticized Karnataka CM Siddaramaiah for his comments linking COVID-19 vaccines to heart attacks. Goyal demande...
- Weekend binge: From 'Fukrey 3' to 'Gen V', wrap up September with a dose of drama & actionGet ready for an action-packed weekend with a diverse lineup of entertainment options that cater to all your cinematic cravings! Whether yo...
- India's vaccination journey shows it leads global fight against pandemic"The airline will have to go through the whole process starting with proving flights, where the airline will have to demonstrate its abilit...
- Third Covid wave of magnitude comparable to first two unlikely to hit India: GuleriaA third Covid wave of a magnitude comparable to the first two is unlikely to hit India, AIIMS director Dr Randeep Guleria said Tuesday as h...
- How Rhesus macaque monkeys were tracked for Covaxin trial!Dr Balram Bhargava says that it is important to remember that the heroes of Covaxin's success story are not just human ones as 20 monkeys a...
- Bharat Biotech proud of contribution to historic landmark: Dr Krishna Ella on COVID vaccination coverage crossing 100 cr markTerming the achievement as a "true success story of Atmanirbharta", he said that it was a unified effort of the government, vaccine manufac...
- Govt will decide on COVID vaccination of children, adolescents on 'scientific rationale', supply situation: V K PaulPaul, who has been playing a key role in the government's efforts in the fight against the coronavirus pandemic, also cautioned that even t...
- Covaxin phase-3 trial data to be out soon, says top executiveMore than five months after the Indian government approved Covaxin, the Hyderabad-based company has yet to publish its phase-3 trial data.
- View: Mutual Nirbharta must to maximise vaccine manufacturing capacityIn this interdependent world, the research on a vaccine, its ingredients and its manufacturers are in different countries. India must never...
- Appalled by Vardhan's statement that there is no shortage of oxygen, vaccines: Chidambaram"I am also appalled by the statement of the UP Chief Minister that there is no shortage of vaccines in UP," he said on Twitter. He asked wh...
- Risk-reward in cyclicals still favourable: Mukul Kochhar“It is a reasonably good environment to be investing in midcaps and we should be looking at this correction as an opportunity.”
- COVID-19: WHO chief scientist says India exhibited capacity to innovate, manufacture vaccinesSpeaking at the Global Bio-India 2021, she opined that the fight against the coronavirus pandemic is at a very critical junction now as cas...
- Recent surge in India's Covid cases major contributor to rising global tally: Soumya Swaminathan, WHO's chief scientistThe WHO is alarmed by the rise of numbers in India, along with Indonesia and Nepal, Swaminathan said while speaking at Global Bio-India 202...
- Medical expert clears the air around COVID-19 vaccinesNew Delhi, To vaccinate or not to vaccinate - is the question on everybody's mind today. But in truth, an informed decision must be made as...
- Covaxin approval sans due process, alleges Manish Tewari"COVAXIN is another story -- Approvals sans Due Process," the former Union minister added, tagging a media report which claimed scientists ...
- Bharat Biotech's Krishna Ella is a scientist who avoids any shortcutsElla never takes shortcuts and scientists at his foundation do more research work than probably any other institution in the country, say p...
- FOMO in travel-linked stocks? No, it seems to be value buyingAmong the hospitality stocks, Indian Hotels has climbed more than 10 per cent in last one week, whole Lemon Tree Hotels has jumped 34 per c...
- What's in a name? It can give a stock 400% leapWhile Bharat Biotech is competing to develop India’s first vaccine for the pandemic, shares of a little-known state-owned company — Bharat ...
Load More
